Provided by Tiger Trade Technology Pte. Ltd.

CMS

10.780
-0.100-0.92%
Volume:17.62M
Turnover:191.40M
Market Cap:26.23B
PE:14.99
High:11.030
Open:10.900
Low:10.710
Close:10.880
52wk High:15.195
52wk Low:9.354
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:3.14
T/O Rate:0.72%
Dividend:0.34
Dividend Rate:3.19%
EPS(LYR):0.719
ROE:8.42%
ROA:5.62%
PB:1.25
PE(LYR):14.99
PS:2.58

Loading ...

China Medical System Holdings (SEHK:867) Valuation After Desidustat Approval And Recent Share Price Pullback

Simply Wall St.
·
Mar 26

China Medical System Wins Desidustat Approval Raising Nephrology Growth Questions

Simply Wall St.
·
Mar 20

China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative

Simply Wall St.
·
Mar 18

Stock Track | CMS Soars 5.09% Intraday After Analyst Upgrade and Target Price Hike

Stock Track
·
Mar 18

Analysts Maintain Outperform Rating on CMS, Raise Target Price to HK$17.50

Stock News
·
Mar 18

CMS (00867) 2025 Net Profit Normalised Up 3.6%; Turnover Rises 9.9% to RMB 8.21 Billion

Bulletin Express
·
Mar 17

China Medical System Holdings - FY Turnover up 9.9% to RMB8,212.1 Mln

THOMSON REUTERS
·
Mar 17

CMS (00867) Declares FY2025 Final Dividend of RMB 0.1366 (HKD 0.155) per Share

Bulletin Express
·
Mar 17

China Medical System Holdings files list of directors with HKEX

Reuters
·
Mar 17

China Medical System Holdings proposes final dividend of RMB 0.1366 per share for FY2025

Reuters
·
Mar 17

CMS (00867) FY2025: Turnover Up 9.9% to RMB 8.21 Billion, Normalised Profit Rises 3.6%; Pipeline Advances with 2 Approvals and 6 NDAs

Bulletin Express
·
Mar 16

CMS Reports 2025 Financial Results: Profit Attributable to Owners Declines 8.08% to Approximately 1.489 Billion Yuan

Stock News
·
Mar 16

China Medical System FY2025 profit fell 10.5% to RMB1.44 billion as turnover rose 9.9% to RMB8.21 billion

Reuters
·
Mar 16

China Medical System Holdings - Profit for Year RMB1,443.3 Mln

THOMSON REUTERS
·
Mar 16

China Medical System Holdings - Proposed Final Dividend of RMB0.1366 per Share

THOMSON REUTERS
·
Mar 16

Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback

Simply Wall St.
·
Mar 14

China Medical System Holdings - Nmpa Approves Desidustat Tablets for Renal Anaemia in China

THOMSON REUTERS
·
Mar 13

China Medical System Gets China Nod to Market Renal Anaemia Drug

MT Newswires
·
Mar 13

CMS Gains Chinese Approval for New Anemia Drug Desidustat

Stock News
·
Mar 13

China Medical System Holdings - New Drug for Renal Anaemia Desidustat Tablets Approved for Marketing by China Nmpa

THOMSON REUTERS
·
Mar 13